Print ISSN:-XXXX

Online ISSN:-XXXX

Issue

Year 2021

Volume: 4 , Issue: 4

Article Access statistics

Viewed: 652

Emailed: 0

PDF Downloaded: 1516

IP Journal of Urology, Nephrology and Hepatology Science


Distal ureteral stone: A challenging case on medical expulsion therapy with tamsulosin and deflazacort combination


Full Text PDF Share on Facebook Share on Twitter


Case Report

Author Details : Prem Kumar, Abhijit Trailokya*, Chetna Gupta, Amrit B. Karmarkar

Volume : 4, Issue : 4, Year : 2021

Article Page : 116-118



Suggest article by email


Abstract

Kidney stones (also called as renal calculi, neprholithasis, or urolithiasis) usually accounts for 15-20% cases in OPD. Distal ureteric calculi are kidney stones that have travelled down from either kidney to ureter and stuck in ureter due to size, shape of calculus or narrow ureter. This report highlights a presentation of case of distal ureteral stone in 35-year-old man. Diagnostic tests such as Ultrasonography, CT Scan and laboratory investigations were done. It was found to be the case of Ureteral stone in left ureterovesical junction with size of 5mm. Combination therapy with alpha blocker (Tamsulosin) and steroid (Deflazacort) was given for a period of 7 days. Stone expulsion time, stone expulsion rate, and requirement of analgesics were studied. It was found that, Tamsulosin with Deflazacort combination is proved to be efficient and has been considered as one of the optimum medical expulsive therapy in the management of symptomatic distal ureteric calculus.

Keywords: Tamsulosin, Deflazacort, Kidney stone, Renal calculi, Neprholithasis, Medical expulsion therapy


How to cite : Kumar P, Trailokya A, Gupta C, Karmarkar A B, Distal ureteral stone: A challenging case on medical expulsion therapy with tamsulosin and deflazacort combination. J Urol Nephrol Hepatol Sci 2021;4(4):116-118

Copyright © 2021 by author(s) and J Urol Nephrol Hepatol Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)